Covington Capital Management’s Aralez Pharmaceuticals Inc. ARLZ Stock Holding History

Covington Capital Management’s Portfolio ARLZ Stock Details ARLZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-21	Closed	–	–	732
2018 Q2	$0	Hold	21	–	–	﹤0.01%	758
2018 Q1	$0	Hold	21	–	–	﹤0.01%	805
2017 Q4	$0	Hold	21	–	–	﹤0.01%	834
2017 Q3	$0	Buy	+21	New	+$28	﹤0.01%	708

Other funds holding ARLZ

Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

Covington Capital Management's ARLZ Position: Q3 2018 in Review

Covington Capital Management sold out of Aralez Pharmaceuticals Inc. (ARLZ) in Q3 2018, closing a stake of 21 shares.

Covington Capital Management first reported a position in ARLZ in Q3 2017 and held it in 4 quarters. The position peaked at $0 in Q2 2018. 4 funds tracked by Wall St. Rank hold ARLZ as of Q3 2018.

Covington Capital Management reported no remaining Aralez Pharmaceuticals Inc. position as of Q3 2018 after selling out during the quarter.
Covington Capital Management sold 21 Aralez Pharmaceuticals Inc. shares in Q3 2018.
Covington Capital Management first reported a position in Aralez Pharmaceuticals Inc. in Q3 2017 and held it in 4 quarters.
Covington Capital Management's Aralez Pharmaceuticals Inc. position peaked at $0 in Q2 2018.
4 funds tracked by Wall St. Rank held Aralez Pharmaceuticals Inc. as of Q3 2018.

Based on Covington Capital Management's 13F filing for Q3 2018, filed 15 Nov 2018.